कृपया अन्य खोज का प्रयास करें
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company’s product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jack A. Khattar | 63 | 2016 | Independent Chairman of the Board |
Klaus R. Veitinger | 62 | 2017 | Independent Director |
Dan Bensimhon | - | - | Member of Scientific Advisory Board |
William S. Weintraub | - | - | Member of Scientific Advisory Board |
William T. Abraham | 64 | 2021 | Independent Director |
Mette Kirstine Agger | 60 | 2014 | Independent Director |
Leonard D. Schaeffer | 78 | 2014 | Independent Director |
Marvin A. Konstam | - | - | Member of Scientific Advisory Board |
Frederick M. Hudson | 79 | 2018 | Independent Director |
John H. Tucker | 61 | 2016 | President, CEO, Principal Executive Officer & Director |
Sara M. Bonstein | 43 | 2020 | Independent Director |
Minnie V. Baylor-Henry | 76 | 2018 | Independent Director |
Stuart Russell | - | - | Member of Scientific Advisory Board |
G. Michael Felker | - | - | Member of Scientific Advisory Board |
William Franklin Peacock | - | - | Member of Scientific Advisory Board |
James E. Udelson | - | - | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है